OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
LILRB1+ immune cell infiltration identifies immunosuppressive microenvironment and dismal outcomes of patients with ovarian cancer
Xiaoyu Xu, Songcheng Yin, Yun Wang, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110162-110162
Closed Access | Times Cited: 8
Xiaoyu Xu, Songcheng Yin, Yun Wang, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110162-110162
Closed Access | Times Cited: 8
Showing 8 citing articles:
Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects
Siyuan Wang, Jiaxin Wang, Yu Xia, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Siyuan Wang, Jiaxin Wang, Yu Xia, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Antitumor Research Based on Drug Delivery Carriers: Reversing the Polarization of Tumor-Associated Macrophages
Xinyu Cao, Shen Wan, Bingyu Wu, et al.
Molecular Pharmaceutics (2025)
Closed Access | Times Cited: 1
Xinyu Cao, Shen Wan, Bingyu Wu, et al.
Molecular Pharmaceutics (2025)
Closed Access | Times Cited: 1
Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer
Tobias Zeller, Ira A. Münnich, Roland Windisch, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
Tobias Zeller, Ira A. Münnich, Roland Windisch, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
Human leukocyte immunoglobulin-like receptors in health and disease
Silvia Redondo-García, Christopher Barritt, Charys Papagregoriou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Silvia Redondo-García, Christopher Barritt, Charys Papagregoriou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
The role of macrophage polarization in ovarian cancer: from molecular mechanism to therapeutic potentials
Chenchen Xu, Jiyu Chen, Mi Tan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Chenchen Xu, Jiyu Chen, Mi Tan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
MHC1/LILRB1 axis as an innate immune checkpoint for cancer therapy
Ziyi Hu, Qiaodong Zhang, Zehua He, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Ziyi Hu, Qiaodong Zhang, Zehua He, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Unraveling the potential biomarkers of immune checkpoint inhibitors in advanced ovarian cancer: a comprehensive review
Jianrong Na, Yaqin Liu, Kun Fang, et al.
Investigational New Drugs (2024)
Closed Access | Times Cited: 1
Jianrong Na, Yaqin Liu, Kun Fang, et al.
Investigational New Drugs (2024)
Closed Access | Times Cited: 1
CAR-T-Cell Therapy Based on Immune Checkpoint Modulation in the Treatment of Hematologic Malignancies
Manqi Su, Zhanna Zhang, Panruo Jiang, et al.
Cell Transplantation (2024) Vol. 33
Open Access | Times Cited: 1
Manqi Su, Zhanna Zhang, Panruo Jiang, et al.
Cell Transplantation (2024) Vol. 33
Open Access | Times Cited: 1
